Marshall Fordyce - PRESIDENT AND CEO, Director at Vera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Issuer Symbol
VERA on Nasdaq
All Insider Reports
All Insider Reports

Marshall Fordyce - trading volume in the past year for Vera Therapeutics, Inc.

Holdings reported by Marshall Fordyce for Vera Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 257,163 $10,796,705 $41.98 23 Feb 2026 Direct
Class A Common Stock 122,949 $5,546,229 $45.11 23 Feb 2026 By GRAT
Class A Common Stock 99,081 $4,469,543 $45.11 23 Feb 2026 By Trust
Stock Option (right to buy) 137,500 04 Feb 2026 Direct Class A Common Stock

Transactions reported by Marshall Fordyce for Vera Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.